Please assess the completion status of the following clinical trial:

Trial Title: Bone Marrow Stem Cell Treatment for Asherman's Syndrome and Endometrial Atrophy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients diagnosed of Asherman Syndrome and absence of pregnancy after treatment~* Endometrial atrophy (\<6mm) with Implantation Failure~* Age 20-45 years-old~* Normal liver, heart and kidney function~* Presence of menstrual bleeding with Natural Cycle or HRT~* Absence of psychiatric pathology and ability to accomplish the treatment~* β-hCG negative~* Absence of SDT~Exclusion Criteria:~* Absence of peripheral vein access~* Lack of accomplish inclusion criteria

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).